Ajanta Pharma
BSE 532331
7 stories, newest first.
- Promoter trust pledges 30,000 shares (0.02%) after top-up call on share price fall
- Ajanta Pharma to release Q2 FY2027 unaudited results on 30 Oct 2026; earnings conference call at 16:00 IST
- Board meeting on 30 October 2026 to consider and approve unaudited Q2 FY2027 results
- Promoter Aayush Agrawal creates pledge on 4,60,000 shares for NCD issue
- Ajanta Pharma Ltd: 2.10% of shares pledged
- Voluntary Sustainability Report for FY 2025-26 submitted to exchanges
- Promoter trust releases pledge on 98,185 shares after loan repayment
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.